CN101156841A - 一种联苯乙酸及其盐的抗肿瘤新用途 - Google Patents
一种联苯乙酸及其盐的抗肿瘤新用途 Download PDFInfo
- Publication number
- CN101156841A CN101156841A CNA2007100297569A CN200710029756A CN101156841A CN 101156841 A CN101156841 A CN 101156841A CN A2007100297569 A CNA2007100297569 A CN A2007100297569A CN 200710029756 A CN200710029756 A CN 200710029756A CN 101156841 A CN101156841 A CN 101156841A
- Authority
- CN
- China
- Prior art keywords
- salt
- felbinac
- cell
- acetic acid
- biphenyl acetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
IC50(μg/ml) | |||||
Hela | A549 | HCT15 | SK-OV-3 | XF498 | |
联苯乙酸 | 0.12±0.01 | 1.83±0.02 | 6.16±0.52 | 1.45±0.12 | 5.70±1.17 |
阿霉素 | 0.42±0.11 | 1.43±0.43 | 3.32±1.21 | 10.01±2.57 | 6.21±2.14 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100297569A CN101156841B (zh) | 2007-08-17 | 2007-08-17 | 一种联苯乙酸及其盐的抗肿瘤新用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100297569A CN101156841B (zh) | 2007-08-17 | 2007-08-17 | 一种联苯乙酸及其盐的抗肿瘤新用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101156841A true CN101156841A (zh) | 2008-04-09 |
CN101156841B CN101156841B (zh) | 2010-09-08 |
Family
ID=39305166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100297569A Active CN101156841B (zh) | 2007-08-17 | 2007-08-17 | 一种联苯乙酸及其盐的抗肿瘤新用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101156841B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536607A (zh) * | 2012-07-10 | 2014-01-29 | 邵金辉 | 土霉素,普罗帕酮和安乃近的抗肿瘤作用 |
CN106983718A (zh) * | 2016-08-12 | 2017-07-28 | 广东中科药物研究有限公司 | 一种联苯乙酸或其氨丁三醇盐注射液的制备方法 |
-
2007
- 2007-08-17 CN CN2007100297569A patent/CN101156841B/zh active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536607A (zh) * | 2012-07-10 | 2014-01-29 | 邵金辉 | 土霉素,普罗帕酮和安乃近的抗肿瘤作用 |
CN106983718A (zh) * | 2016-08-12 | 2017-07-28 | 广东中科药物研究有限公司 | 一种联苯乙酸或其氨丁三醇盐注射液的制备方法 |
CN106983718B (zh) * | 2016-08-12 | 2019-01-11 | 广东中科药物研究有限公司 | 一种联苯乙酸或其氨丁三醇盐注射液的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101156841B (zh) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103385912B (zh) | 猴耳环提取物及其在制备抗耐甲氧西林金黄色葡萄球菌药物中的应用 | |
CN103877101A (zh) | 葫芦素在制备抗肿瘤药物中的应用 | |
CN100522184C (zh) | 具有抗肿瘤和抗毒活性的提取物 | |
CN109331006B (zh) | 一种紫杉醇和榄香烯分子配伍药物组合物及其应用 | |
CN101156841B (zh) | 一种联苯乙酸及其盐的抗肿瘤新用途 | |
CN105380956B (zh) | 一种治疗白血病的含艾德拉尼的药物组合物及应用 | |
CN101129387A (zh) | 葫芦素在治疗癌症方面的新的医药用途 | |
CN101313928A (zh) | 青蒿油及其制剂的医药用途 | |
CN104055786B (zh) | 苜蓿酸-3-O-β-D-吡喃葡萄糖苷、苜蓿酸及其盐在制备防治肿瘤药物中的应用 | |
CN105902561A (zh) | 龙须菜多糖作为抗肿瘤化疗药增效剂的应用及抗肿瘤药物 | |
CN113318149A (zh) | 一种素馨花提取物及其制备方法和应用 | |
CN104382928A (zh) | 罗勒多糖用作抗肿瘤化疗药增效剂在制备抗肿瘤药物中的应用 | |
CN101199534B (zh) | 一种原人参二醇衍生物的抗肿瘤用途 | |
CN103877126B (zh) | 瘤盖拟层孔菌的药用用途及***的药物组合物 | |
CN113368090B (zh) | 3,4-裂环环阿屯烷型四环三萜化合物或其药学上可接受的盐在制备抗癌药物中的用途 | |
CN111840523B (zh) | 一种含活性蛋白和活性脂肪酸的抗癌症的药物组合物 | |
CN103520323B (zh) | 胆木提取物及其在制备抗耐甲氧西林金黄色葡萄球菌药物中的应用 | |
CN102397273A (zh) | 穿心莲内酯的医药新用途 | |
CN107184912A (zh) | 一种养正消积复方制剂及其应用 | |
CN103417542B (zh) | 一种治疗白血病的口服固体制剂及应用 | |
CN109602775B (zh) | 乳苣醇提物在制备抗乳腺癌药物中的用途 | |
WO2022222388A1 (zh) | L-山梨糖在制备***的药物中的应用 | |
CN102232957A (zh) | 3-乙酰氧基-8,24-羊毛甾二烯-21-酸的抗肿瘤活性及其在医药中的应用 | |
CN104490934B (zh) | 一种药物组合物及其用途 | |
CN106831386A (zh) | 新型蕨素类化合物在治疗糖尿病的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGDONG ZONK DRUG R + D LIMITED Free format text: FORMER OWNER: CHEN WENZHAN Effective date: 20120626 Free format text: FORMER OWNER: WANG WEI Effective date: 20120626 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510630 GUANGZHOU, GUANGDONG PROVINCE TO: 510663 GUANGZHOU, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120626 Address after: 510663 Guangdong Guangzhou city Luogang District Science City Road No. 3, international business incubator A District 1105 Patentee after: Guangdong Zonk Drug R & D Limited Address before: 510630 Guangdong city of Guangzhou province Guangzhou city Tianhe District Whampoa Road West, No. 601 and Suzhou court 37 Building 205 room Co-patentee before: Wang Wei Patentee before: Chen Wenzhan |
|
ASS | Succession or assignment of patent right |
Owner name: YILING PHARMACEUTICAL CO. LTD., SHIJIAZHUANG Free format text: FORMER OWNER: GUANGDONG ZONK DRUG R + D LIMITED Effective date: 20120725 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510663 GUANGZHOU, GUANGDONG PROVINCE TO: 050035 SHIJIAZHUANG, HEBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120725 Address after: 050035 Shijiazhuang City, Hebei Province, Tianshan Road, No. 238 Patentee after: Shijiazhuang Yiling Pharmaceutical Co., Ltd. Address before: 510663 Guangdong Guangzhou city Luogang District Science City Road No. 3, international business incubator A District 1105 Patentee before: Guangdong Zonk Drug R & D Limited |